Roche receives FDA approval for first companion diagnostic to identify endometrial cancer patients eligible for immunotherapy

About 90,000 women globally die from endometrial cancer each year1 VENTANA MMR RxDx Panel is the first immunohistochemistry predictive test in endometrial cancer for treatment with the anti-PD1 immunotherapy JEMPERLI (dostarlimab-gxly) Roche/GSK collaboration represents an important step towards a personalised healthcare strategy that can help identify patients who are most likely to benefit from a... Read more

Pacific Biosciences Grants Equity Incentive Award to New Employee

MENLO PARK, Calif., April 22, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality sequencing of genomes, transcriptomes, and epigenomes, today announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 80,000 shares of... Read more

Pacific Biosciences Grants Equity Incentive Award to New Employee

MENLO PARK, Calif., April 22, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) (“Pacific Biosciences” or the “Company”), a leading provider of high-quality sequencing of genomes, transcriptomes, and epigenomes, today announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 80,000 shares of... Read more

Danaher Reports First Quarter 2021 Results

WASHINGTON, April 22, 2021 /PRNewswire/ — Danaher Corporation (NYSE: DHR) (the “Company”) today announced results for the first quarter 2021.  All results in this release reflect only continuing operations unless otherwise noted. For the quarter ended April 2, 2021, net earnings were $1.7 billion, or $2.29 per diluted common share which represents a 182.5% year-over-year... Read more

Roche reports solid results in the first quarter of 2021

Basel, 21 April 2021 Group sales increase 3%1 at constant exchange rates (CER); 1% decline in Swiss francs, as a result of the appreciation of the Swiss franc Pharmaceuticals Division sales: Continued strong growth of new medicines (+20%) As expected, significant impact from biosimilars (CHF -1.6 billion) Base effect from the strong first quarter 2020... Read more

Agilent Named One of the Best U.S. Companies for Diversity for Third Straight Year

SANTA CLARA, Calif., April 20, 2021  Agilent Technologies (NYSE: A) today was named one of the top U.S. companies for diversity, marking the third straight year it has been recognized for its commitment to fostering a diverse and inclusive workplace. Specifically, Agilent ranked No. 83 out of 500 companies on Forbes’s 2021 list of America’s Best Employers... Read more

Brooks Automation Announces Fiscal 2021 Second Quarter Earnings Conference Call and Webcast

Brooks Automation Announces Fiscal 2021 Second Quarter Earnings Conference Call and Webcast CHELMSFORD, Mass., April 19, 2021 /PRNewswire/ — Brooks Automation, Inc. (Nasdaq: BRKS) will announce fiscal 2021 second quarter which ended on March 31, 2021 on Monday, May 10, 2021 after the market closes. The Company will host a conference call and live webcast to... Read more

Bio-Techne Announces Launch of Professional Assay Services – Dedicated Source for RNA In Situ Hybridization Assays in Spatial Gene Expression Analysis

APRIL 15, 2021 MINNEAPOLIS, April 15, 2021 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) today announced that Advanced Cell Diagnostics (ACD), a Bio-Techne brand, completed an extensive rebranding effort in response to increased demand for its Assay Services offered at its Newark, CA laboratory. At the heart of this re-launch is a name change from Pharma... Read more

Pacific Biosciences of California, Inc. First Quarter 2021 Financial Results Call

MENLO PARK, Calif., April 15, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its first quarter 2021 financial results on Thursday, April 29, 2021, at 4:30pm Eastern Time. The call will be webcast and may be accessed at Pacific Biosciences’ website at: https://investor.pacificbiosciences.com/. Date:... Read more